会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • SAK: modulation of cellular proliferation for treatment of cancer
    • SAK:调节细胞增殖治疗癌症
    • US07413870B2
    • 2008-08-19
    • US10026021
    • 2001-12-21
    • Yasumichi HitoshiSusan DemoYonchu Jenkins
    • Yasumichi HitoshiSusan DemoYonchu Jenkins
    • C12Q1/50
    • G01N33/57484A61K38/00A61K2039/505G01N2333/912
    • The present invention relates to regulation of cellular proliferation. More particularly, the present invention is directed to nucleic acids encoding SAK, which is a protein kinase involved in modulation of cellular proliferation and cell cycle regulation. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions, antibodies, peptides, cyclic peptides, nucleic acids, RNAi, antisense nucleic acids, and ribozymes, that modulate cell cycle regulation and cellular proliferation via modulation of SAK; as well as to the use of expression profiles and compositions in diagnosis and therapy related to cell cycle regulation and modulation of cellular proliferation, e.g., for treatment of cancer and other diseases of cellular proliferation.
    • 本发明涉及细胞增殖的调控。 更具体地,本发明涉及编码SAK的核酸,其是参与调节细胞增殖和细胞周期调节的蛋白激酶。 本发明还涉及用于鉴别和使用通过调节SAK调节细胞周期调节和细胞增殖的试剂,包括小分子化学组合物,抗体,肽,环肽,核酸,RNAi,反义核酸和核酶的方法; 以及在细胞周期调控和细胞增殖调节相关的诊断和治疗中使用表达谱和组合物,例如用于治疗癌症和其它细胞增殖疾病。
    • 5. 发明申请
    • Methods of assaying for cell cycle modulators
    • 测定细胞周期调节剂的方法
    • US20060051755A1
    • 2006-03-09
    • US10510903
    • 2003-04-15
    • Yasumichi HitoshiYonchu Jenkins
    • Yasumichi HitoshiYonchu Jenkins
    • C12Q1/68
    • G01N33/5091C12Q1/6886C12Q2600/158G01N33/5008G01N33/5011G01N33/574G01N33/6872G01N2333/4703G01N2500/00
    • The present invention relates to regulation of cellular proliferation. More particularly, the present invention is directed to nucleic acids encoding BRCA-1-Associated Protein-1 (BAP-1), Nuclear Protein 95 (NP95), Fanconi anemia group A protein (FANCA), DEAD/H box polypeptide 9 (DDX9), insulin-like growth factor 1 receptor (IGF1R), ubiquitin-conjugating enzyme E2 variant 1 (UBE2V1), aldehyde dehydrogenase, pyruvate kinase, glucose-6-phosphate dehydrogenase, HCDR-3, DEAD/H box polypeptide 21 (DDX21), serine threonine kinase 15 (ARK2), transmembrane 4 superfamily member 1, or ERCC1, which are involved in modulation of cell cycle arrest. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions, antibodies, peptides, cyclic peptides, nucleic acids, RNAi, antisense nucleic acids, and ribozymes, that modulate cell cycle arrest via modulation of BRCA-1-Associated Protein-1 (BAP-1), Nuclear Protein 95 (NP95), Fanconi anemia group A protein (FANCA), DEAD/H box polypeptide 9 (DDX9), insulin-like growth factor 1 receptor (IGF1R), ubiquitin-conjugating enzyme E2 variant 1 (UBE2V1), aldehyde dehydrogenase, pyruvate kinase, glucose-6-phosphate dehydrogenase, HCDR-3, DEAD/H box polypeptide 21 (DDX21), serine threonine kinase 15 (ARK2), transmembrane 4 superfamily member 1, or ERCC1, as well as to the use of expression profiles and compositions in diagnosis and therapy related to cell cycle regulation and modulation of cellular proliferation, e.g., for treatment of cancer and other diseases of cellular proliferation.
    • 本发明涉及细胞增殖的调控。 更具体地,本发明涉及编码BRCA-1相关蛋白-1(BAP-1),核蛋白95(NP95),Fanconi贫血A组蛋白(FANCA),DEAD / H盒多肽9(DDX9) ),胰岛素样生长因子1受体(IGF1R),泛素结合酶E2变体1(UBE2V1),醛脱氢酶,丙酮酸激酶,葡萄糖-6-磷酸脱氢酶,HCDR-3,DEAD / H盒多肽21(DDX21) ,丝氨酸苏氨酸激酶15(ARK2),跨膜4超家族成员1或ERCC1,其参与调节细胞周期停滞。 本发明还涉及用于鉴定和使用包括小分子化学组合物,抗体,肽,环肽,核酸,RNAi,反义核酸和核酶在内的试剂的方法,其通过调节BRCA-1相关的调节细胞周期阻滞 蛋白-1(BAP-1),核蛋白95(NP95),Fanconi贫血组A蛋白(FANCA),DEAD / H盒多肽9(DDX9),胰岛素样生长因子1受体(IGF1R),泛素缀合酶 E2变体1(UBE2V1),醛脱氢酶,丙酮酸激酶,葡萄糖-6-磷酸脱氢酶,HCDR-3,DEAD / H盒多肽21(DDX21),丝氨酸苏氨酸激酶15(ARK2),跨膜4超家族成员1或ERCC1 ,以及在与细胞周期调节和细胞增殖调节相关的诊断和治疗中使用表达谱和组合物,例如用于治疗癌症和其他细胞增殖疾病。